1Ronner E,Dykun T,Brand VD,et al.Plated glycoproteinⅡb Ⅲa a receptor antagonists.An assesmont for treatment of unstable coronary syndromes and coronary intervention[].European Heart Journal.1998
2Ryan TJ,Anderson JL,Antman EM,et al.ACC AHA guidelines for the management of patients with acute myocardial infarction; executive summary[].Circulation.1996
3LATE study group.Late Assesment of Throbolytic Efficacy( LATE ) study with alteplase 6 ~ 24 hours after anset of myocardial infarction[].The Lancet.1993
4OhmanEM,KleimanNS,GaciochG,et al.For theIMPACT-AMI investigators.Combined accelerated tissue-plasminogenactivator and platelet glycoprotein b/ a integrin receptorblockade with integrilin in acute myocardial infarction:resultsof a randomized,placebo-controlled,dose-ranging trial[].Circulation.1997
5The PURSUIT trial investigators.Inhibition of platelet glycoprotein Ⅱ b Ⅲ a with eptifibatide in patients with acute coronary syndromes[].The New England Journal of Medicine.1998
6The Gusto investigators.An internation randomised trial comparing four thrombolytic strategies for acute myocardial infarction[].The New England Journal of Medicine.1993
7Von Arnim T.Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis.Results of the total ischemic burden Bisoprolol study (TIBBS)follow-up[].Journalism Assn of Community College.1996
8The PRISM-PLUS study investigators.Inhibition of the platelet glycoprotein Ⅱb Ⅲa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction[].The New England Journal of Medicine.1998
9Kleiman NS,Ohman ME,Califf RM,et al.Profound inhibition of platelet aggregation with moncolonal antibody 7E3 following thrombolytic therapy: results of the TIMI 8 pilot study[].Journal of the American College of Cardiology.1993
10The PRISM study investigators.A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angian[].The New England Journal of Medicine.1998
